Revive Therapeutics Ltd
Change company Symbol lookup
Select an option...
RVVTF Revive Therapeutics Ltd
TCEHY Tencent Holdings Ltd
GCO Genesco Inc
$RFTREES Refinitiv Eurozone ESG Select Index
PFC Premier Financial Corp (OHIO)
TWTR Twitter Inc
BCEI Bonanza Creek Energy Inc
RNGR Ranger Energy Services Inc
BAC Bank of America Corp
DIS Walt Disney Co

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

Day's Change
-0.0124 (-2.52%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 681,209 shares is on pace to be much greater than RVVTF's 10-day average volume of 1,887,346 shares.

  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    10:31a ET 01/15/21
  • Last (size)
  • 52-Wk Range
    0.03 - 0.72
  • (03/19/20 - 12/14/20)
  • 204.7%
  • Market Cap
  • Shares Outstanding
  • -0.05
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -0.1
  • 0.12
  • --

Latest News

January 14, 2021
7:00 am ET
Globe Newswire
January 07, 2021
9:00 am ET
PR Newswire
December 31, 2020
7:00 am ET
Globe Newswire
December 23, 2020
12:43 pm ET
Globe Newswire
December 21, 2020
7:59 am ET
Globe Newswire
7:59 am ET
Globe Newswire
December 16, 2020
8:45 am ET
PR Newswire
December 15, 2020
9:01 am ET
PR Newswire
December 14, 2020
9:00 am ET
PR Newswire
December 02, 2020
1:11 pm ET
Globe Newswire
November 18, 2020
7:02 am ET
Globe Newswire
November 11, 2020
9:09 am ET
Globe Newswire
November 02, 2020
10:53 am ET
PR Newswire
October 26, 2020
9:21 am ET
Globe Newswire
October 20, 2020
8:00 am ET
7:22 am ET
Globe Newswire
Go to all current & historical news


There are no calendar events for RVVTF.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.